Carmolex, Inc., USA, is Pleased to Announce it has Entered into an…

Carmolex's advanced solutions/platform is poised to deliver Sanofi in Germany with a diverse set of high-quality chemotypes, pre-clinical, low molecular weight hits against biologically relevant...

(PRWeb October 18, 2012)

Read the full story at http://www.prweb.com/releases/2012/10/prweb10016134.htm


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: